Categories AlphaGraphs, Earnings, LATEST, Technology
Keysight Technologies tops Q3 estimates; lifts 2019 outlook
Keysight Technologies (NYSE: KEYS) rose about 7% in the extended hours as the company beat third quarter 2019 estimates and raised the fiscal 2019 outlook. GAAP revenue and non-GAAP revenue, both grew 8% to $1.087 billion and $1.088 billion, respectively. Non-GAAP EPS grew 41% to $1.25 in the third quarter ended July 31, 2019.
Analysts had projected the company to post earnings of $1.02 per share on revenue of $1.05 billion. Keysight shares ended up 2.11% at $89.14 today.
The Santa Rosa, California-based firm lifted its non-GAAP revenue outlook for fiscal 2019. The company now expects full-year non-GAAP revenue growth to be between 9% and 10% versus the previous growth guidance of 7% and 8%.
Keysight’s fourth quarter 2019 GAAP revenue is expected to be in the range of $1.078 billion to $1.098 billion and non-GAAP revenue is expected to be in the range of $1.080 billion to $1.100 billion. Non-GAAP EPS for Q4 is expected to be in the range of $1.14 to $1.20.
“Keysight delivered another excellent quarter with both revenue and earnings exceeding the high-end of our guidance. Record third quarter revenue was driven by growth across the majority of our end markets as we continued to capture a significant portion of the demand we see in the marketplace,” said CEO Ron Nersesian.
Non-GAAP revenue from Commercial Communications and Electronic Industrial Solutions end markets increased 23%, and 3%, respectively. However, non-GAAP revenue from Aerospace, Defense & Government and Ixia Solutions end markets registered a decline of 1% and 7%, respectively in the third quarter.
KEYS stock, which reached a 52-week high on July 1, had gained 43% so far this year and 47% in the trailing 12 months.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on